Huhtamaki India (509820) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
Q3 2026 net sales rose 23.7% YoY to Rs. 7,481 million; EBIT before exceptional items was Rs. 521 million, broadly flat YoY.
9M 2026 net sales grew 15.7% to Rs. 20,704 million; EBIT before exceptional items rose 22% to Rs. 1,528 million.
Financial highlights
Q3 EBITDA was Rs. 656 million, up 1.2% YoY; reported PBT was Rs. 394.3 million and PAT was Rs. 297.3 million, down 19.1%.
Q3 revenue from operations was Rs. 7,688.4 million versus Rs. 6,247.3 million YoY.
9M EBITDA rose 24.6% to Rs. 2,042 million; reported PBT increased 13.6% to Rs. 1,333 million and PAT rose 12.8% to Rs. 990.6 million.
9M revenue from operations was Rs. 21,319.6 million versus Rs. 18,468.9 million YoY.
Outlook and guidance
Priorities include profitable growth, disciplined capital allocation, accountability and execution; no specific margin forecast was provided.
Raw-material cost increases are expected to flow through to customer pricing in subsequent months, with timing varying by contract.
Productivity plans remain on track, with focus on high-value products and portfolio mix to support profitability.
Existing capacity and efficiency initiatives are expected to support demand for 2–3 years without major capacity-expansion investment.
Latest events from Huhtamaki India
- Revenue rose 9% as EBIT surged 45.8%, while gross debt fell 32%.509820
Q4 2019 - COVID disruption cut earnings, while exports and sustainability investments supported the path forward.509820
Q4 2020 - Sales grew, but inflation, VRS costs and working capital drove a loss and higher debt.509820
Q4 2021 - Land-sale gains lifted PAT as operating margins improved despite lower revenue.509820
Q4 2023 - Sales grew, but costs and depreciation pressured earnings as new capacity came onstream.509820
Q4 2007 - Core sales grew 33%, while price pressure and higher interest weighed on FY97.509820
Q4 96/97 - Sales and volume advanced, but higher costs and price pressure cut FY 1997-98 profit.509820
Q4 97/98 - Profit rebounded as expansion and Van Leer funding met persistent pricing and input-cost pressure.509820
Q4 98/99 - Sales grew 12.2% in 2000, but input inflation and weak H2 demand squeezed margins.509820
Q4 2000